These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 17332667

  • 1. Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor--evidence from epidemiological and prospective clinical trials.
    Szuba A, Podgórski M.
    Pharmacol Rep; 2006; 58 Suppl():16-20. PubMed ID: 17332667
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor.
    Böger RH.
    J Nutr; 2004 Oct; 134(10 Suppl):2842S-2847S; discussion 2853S. PubMed ID: 15465797
    [Abstract] [Full Text] [Related]

  • 6. Association of asymmetric dimethylarginine and endothelial dysfunction.
    Böger RH.
    Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ADMA: its role in vascular disease.
    Cooke JP.
    Vasc Med; 2005 Jul; 10 Suppl 1():S11-7. PubMed ID: 16444864
    [Abstract] [Full Text] [Related]

  • 9. Asymmetric dimethylarginine: clinical applications in pediatric medicine.
    Tain YL, Huang LT.
    J Formos Med Assoc; 2011 Feb; 110(2):70-7. PubMed ID: 21377060
    [Abstract] [Full Text] [Related]

  • 10. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.
    Sydow K, Mondon CE, Cooke JP.
    Vasc Med; 2005 Jul; 10 Suppl 1():S35-43. PubMed ID: 16444867
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ADMA and hyperhomocysteinemia.
    Dayal S, Lentz SR.
    Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [Abstract] [Full Text] [Related]

  • 13. Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.
    De Gennaro Colonna V, Bianchi M, Pascale V, Ferrario P, Morelli F, Pascale W, Tomasoni L, Turiel M.
    Med Sci Monit; 2009 Apr; 15(4):RA91-101. PubMed ID: 19333216
    [Abstract] [Full Text] [Related]

  • 14. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
    Böger RH, Bode-Böger SM.
    Semin Thromb Hemost; 2000 Apr; 26(5):539-45. PubMed ID: 11129410
    [Abstract] [Full Text] [Related]

  • 15. The clinical significance of asymmetric dimethylarginine.
    Siroen MP, Teerlink T, Nijveldt RJ, Prins HA, Richir MC, van Leeuwen PA.
    Annu Rev Nutr; 2006 Apr; 26():203-28. PubMed ID: 16848705
    [Abstract] [Full Text] [Related]

  • 16. Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.
    Ueda S, Yamagishi SI, Matsumoto Y, Fukami K, Okuda S.
    Clin Exp Nephrol; 2007 Jun; 11(2):115-121. PubMed ID: 17593510
    [Abstract] [Full Text] [Related]

  • 17. [Asymmetric dimethylarginine: predictor of cardiovascular diseases?].
    Németh B, Kustán P, Németh Á, Lenkey Z, Cziráki A, Kiss I, Sulyok E, Ajtay Z.
    Orv Hetil; 2016 Mar 27; 157(13):483-7. PubMed ID: 26996894
    [Abstract] [Full Text] [Related]

  • 18. Biological functional relevance of asymmetric dimethylarginine (ADMA) in cardiovascular disease.
    Franceschelli S, Ferrone A, Pesce M, Riccioni G, Speranza L.
    Int J Mol Sci; 2013 Dec 16; 14(12):24412-21. PubMed ID: 24351825
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Does ADMA cause endothelial dysfunction?
    Cooke JP.
    Arterioscler Thromb Vasc Biol; 2000 Sep 16; 20(9):2032-7. PubMed ID: 10978245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.